You just read:

NW Bio Announces Two German Approvals: "Hospital Exemption" for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement

News provided by

Northwest Biotherapeutics, Inc.

10 Mar, 2014, 12:00 GMT